0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Blood Screening Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-8M16852
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Nucleic Acid Blood Screening Market Research Report 2024
BUY CHAPTERS

Global Nucleic Acid Blood Screening Market Research Report 2025

Code: QYRE-Auto-8M16852
Report
June 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nucleic Acid Blood Screening Market Size

The global market for Nucleic Acid Blood Screening was valued at US$ 4434 million in the year 2024 and is projected to reach a revised size of US$ 7531 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Nucleic Acid Blood Screening Market

Nucleic Acid Blood Screening Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nucleic Acid Blood Screening competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nucleic acid blood screening is a blood safety detection method based on molecular biology technology. Its core lies in the early diagnosis and risk elimination of viral, bacterial and other pathogen infections by specifically amplifying and detecting the nucleic acid sequences (DNA or RNA) of pathogens in blood samples. This technology uses nucleic acid amplification detection (NAT) platforms (such as real-time fluorescence quantitative PCR, transcription-mediated amplification, etc.) to identify extremely low concentrations of pathogen nucleic acids in the blood with high sensitivity and specificity. It is particularly suitable for screening samples in the "window period" of infection that cannot be covered by traditional serological tests, thereby significantly reducing the risk of transfusion-transmitted infections (TTIs) and ensuring the safety of clinical blood use. Its detection targets include blood-borne disease pathogens such as HBV, HCV, and HIV, and has become a key link in blood quality control in modern transfusion medicine.
The current nucleic acid blood screening market is showing a steady growth trend worldwide. The North American market is dominant due to the popularization of nucleic acid detection technology and policy support, while the Asia-Pacific region has become the fastest growing region due to its aging population, increased medical expenditures and improved infrastructure. On the technical level, NAT (nucleic acid amplification detection) occupies the largest market share, and its high sensitivity drives the demand of end users such as blood banks and hospitals. Emerging economies such as India, the Middle East and Africa show high growth potential due to increased medical spending and disposable income, but challenges such as high technology costs and shortage of skilled personnel still restrict market development. In the future, with the iteration of testing technology and the increasing global attention to blood safety, the market is expected to usher in opportunities for continued expansion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Blood Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Blood Screening.
The Nucleic Acid Blood Screening market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Blood Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Blood Screening manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nucleic Acid Blood Screening Market Report

Report Metric Details
Report Name Nucleic Acid Blood Screening Market
Accounted market size in year US$ 4434 million
Forecasted market size in 2031 US$ 7531 million
CAGR 7.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Blood Screening Equipment
  • blood Screening Reagents
Segment by Application
  • Blood Center
  • Central Blood Station
  • Central Blood Bank
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Grifols Diagnostic Solutions, KHB, Bacme Bio, Daan Gene, Wantai Biotechnology, Sansure Biotech, Zhuhai Livzon Reagents, Bio-Rad Laboratories, Horiba, Thermo Fisher Scientific, bioMerieux, Danaher, Abbott, BD, Mindray
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nucleic Acid Blood Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nucleic Acid Blood Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nucleic Acid Blood Screening Market growing?

Ans: The Nucleic Acid Blood Screening Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Nucleic Acid Blood Screening Market size in 2031?

Ans: The Nucleic Acid Blood Screening Market size in 2031 will be US$ 7531 million.

Who are the main players in the Nucleic Acid Blood Screening Market report?

Ans: The main players in the Nucleic Acid Blood Screening Market are Roche, Grifols Diagnostic Solutions, KHB, Bacme Bio, Daan Gene, Wantai Biotechnology, Sansure Biotech, Zhuhai Livzon Reagents, Bio-Rad Laboratories, Horiba, Thermo Fisher Scientific, bioMerieux, Danaher, Abbott, BD, Mindray

What are the Application segmentation covered in the Nucleic Acid Blood Screening Market report?

Ans: The Applications covered in the Nucleic Acid Blood Screening Market report are Blood Center, Central Blood Station, Central Blood Bank

What are the Type segmentation covered in the Nucleic Acid Blood Screening Market report?

Ans: The Types covered in the Nucleic Acid Blood Screening Market report are Blood Screening Equipment, blood Screening Reagents

1 Nucleic Acid Blood Screening Market Overview
1.1 Product Definition
1.2 Nucleic Acid Blood Screening by Type
1.2.1 Global Nucleic Acid Blood Screening Market Value Comparison by Type (2024 VS 2031)
1.2.2 Blood Screening Equipment
1.2.3 blood Screening Reagents
1.3 Nucleic Acid Blood Screening by Application
1.3.1 Global Nucleic Acid Blood Screening Market Value by Application (2024 VS 2031)
1.3.2 Blood Center
1.3.3 Central Blood Station
1.3.4 Central Blood Bank
1.4 Global Nucleic Acid Blood Screening Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Blood Screening Revenue 2020-2031
1.4.2 Global Nucleic Acid Blood Screening Sales 2020-2031
1.4.3 Global Nucleic Acid Blood Screening Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nucleic Acid Blood Screening Market Competition by Manufacturers
2.1 Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nucleic Acid Blood Screening Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nucleic Acid Blood Screening, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nucleic Acid Blood Screening, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Blood Screening, Product Type & Application
2.7 Global Key Manufacturers of Nucleic Acid Blood Screening, Date of Enter into This Industry
2.8 Global Nucleic Acid Blood Screening Market Competitive Situation and Trends
2.8.1 Global Nucleic Acid Blood Screening Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nucleic Acid Blood Screening Players Market Share by Revenue
2.8.3 Global Nucleic Acid Blood Screening Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nucleic Acid Blood Screening Market Scenario by Region
3.1 Global Nucleic Acid Blood Screening Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nucleic Acid Blood Screening Sales by Region: 2020-2031
3.2.1 Global Nucleic Acid Blood Screening Sales by Region: 2020-2025
3.2.2 Global Nucleic Acid Blood Screening Sales by Region: 2026-2031
3.3 Global Nucleic Acid Blood Screening Revenue by Region: 2020-2031
3.3.1 Global Nucleic Acid Blood Screening Revenue by Region: 2020-2025
3.3.2 Global Nucleic Acid Blood Screening Revenue by Region: 2026-2031
3.4 North America Nucleic Acid Blood Screening Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Blood Screening Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nucleic Acid Blood Screening Sales by Country (2020-2031)
3.4.3 North America Nucleic Acid Blood Screening Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nucleic Acid Blood Screening Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Blood Screening Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nucleic Acid Blood Screening Sales by Country (2020-2031)
3.5.3 Europe Nucleic Acid Blood Screening Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Blood Screening Market Facts & Figures by Region
3.6.1 Asia Pacific Nucleic Acid Blood Screening Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nucleic Acid Blood Screening Sales by Region (2020-2031)
3.6.3 Asia Pacific Nucleic Acid Blood Screening Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nucleic Acid Blood Screening Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Blood Screening Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nucleic Acid Blood Screening Sales by Country (2020-2031)
3.7.3 Latin America Nucleic Acid Blood Screening Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nucleic Acid Blood Screening Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Blood Screening Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nucleic Acid Blood Screening Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nucleic Acid Blood Screening Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Blood Screening Sales by Type (2020-2031)
4.1.1 Global Nucleic Acid Blood Screening Sales by Type (2020-2025)
4.1.2 Global Nucleic Acid Blood Screening Sales by Type (2026-2031)
4.1.3 Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2031)
4.2 Global Nucleic Acid Blood Screening Revenue by Type (2020-2031)
4.2.1 Global Nucleic Acid Blood Screening Revenue by Type (2020-2025)
4.2.2 Global Nucleic Acid Blood Screening Revenue by Type (2026-2031)
4.2.3 Global Nucleic Acid Blood Screening Revenue Market Share by Type (2020-2031)
4.3 Global Nucleic Acid Blood Screening Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nucleic Acid Blood Screening Sales by Application (2020-2031)
5.1.1 Global Nucleic Acid Blood Screening Sales by Application (2020-2025)
5.1.2 Global Nucleic Acid Blood Screening Sales by Application (2026-2031)
5.1.3 Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2031)
5.2 Global Nucleic Acid Blood Screening Revenue by Application (2020-2031)
5.2.1 Global Nucleic Acid Blood Screening Revenue by Application (2020-2025)
5.2.2 Global Nucleic Acid Blood Screening Revenue by Application (2026-2031)
5.2.3 Global Nucleic Acid Blood Screening Revenue Market Share by Application (2020-2031)
5.3 Global Nucleic Acid Blood Screening Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Nucleic Acid Blood Screening Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Grifols Diagnostic Solutions
6.2.1 Grifols Diagnostic Solutions Company Information
6.2.2 Grifols Diagnostic Solutions Description and Business Overview
6.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Portfolio
6.2.5 Grifols Diagnostic Solutions Recent Developments/Updates
6.3 KHB
6.3.1 KHB Company Information
6.3.2 KHB Description and Business Overview
6.3.3 KHB Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.3.4 KHB Nucleic Acid Blood Screening Product Portfolio
6.3.5 KHB Recent Developments/Updates
6.4 Bacme Bio
6.4.1 Bacme Bio Company Information
6.4.2 Bacme Bio Description and Business Overview
6.4.3 Bacme Bio Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bacme Bio Nucleic Acid Blood Screening Product Portfolio
6.4.5 Bacme Bio Recent Developments/Updates
6.5 Daan Gene
6.5.1 Daan Gene Company Information
6.5.2 Daan Gene Description and Business Overview
6.5.3 Daan Gene Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Daan Gene Nucleic Acid Blood Screening Product Portfolio
6.5.5 Daan Gene Recent Developments/Updates
6.6 Wantai Biotechnology
6.6.1 Wantai Biotechnology Company Information
6.6.2 Wantai Biotechnology Description and Business Overview
6.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Wantai Biotechnology Nucleic Acid Blood Screening Product Portfolio
6.6.5 Wantai Biotechnology Recent Developments/Updates
6.7 Sansure Biotech
6.7.1 Sansure Biotech Company Information
6.7.2 Sansure Biotech Description and Business Overview
6.7.3 Sansure Biotech Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sansure Biotech Nucleic Acid Blood Screening Product Portfolio
6.7.5 Sansure Biotech Recent Developments/Updates
6.8 Zhuhai Livzon Reagents
6.8.1 Zhuhai Livzon Reagents Company Information
6.8.2 Zhuhai Livzon Reagents Description and Business Overview
6.8.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Portfolio
6.8.5 Zhuhai Livzon Reagents Recent Developments/Updates
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Company Information
6.9.2 Bio-Rad Laboratories Description and Business Overview
6.9.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Portfolio
6.9.5 Bio-Rad Laboratories Recent Developments/Updates
6.10 Horiba
6.10.1 Horiba Company Information
6.10.2 Horiba Description and Business Overview
6.10.3 Horiba Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Horiba Nucleic Acid Blood Screening Product Portfolio
6.10.5 Horiba Recent Developments/Updates
6.11 Thermo Fisher Scientific
6.11.1 Thermo Fisher Scientific Company Information
6.11.2 Thermo Fisher Scientific Description and Business Overview
6.11.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Portfolio
6.11.5 Thermo Fisher Scientific Recent Developments/Updates
6.12 bioMerieux
6.12.1 bioMerieux Company Information
6.12.2 bioMerieux Description and Business Overview
6.12.3 bioMerieux Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.12.4 bioMerieux Nucleic Acid Blood Screening Product Portfolio
6.12.5 bioMerieux Recent Developments/Updates
6.13 Danaher
6.13.1 Danaher Company Information
6.13.2 Danaher Description and Business Overview
6.13.3 Danaher Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Danaher Nucleic Acid Blood Screening Product Portfolio
6.13.5 Danaher Recent Developments/Updates
6.14 Abbott
6.14.1 Abbott Company Information
6.14.2 Abbott Description and Business Overview
6.14.3 Abbott Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Abbott Nucleic Acid Blood Screening Product Portfolio
6.14.5 Abbott Recent Developments/Updates
6.15 BD
6.15.1 BD Company Information
6.15.2 BD Description and Business Overview
6.15.3 BD Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BD Nucleic Acid Blood Screening Product Portfolio
6.15.5 BD Recent Developments/Updates
6.16 Mindray
6.16.1 Mindray Company Information
6.16.2 Mindray Description and Business Overview
6.16.3 Mindray Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mindray Nucleic Acid Blood Screening Product Portfolio
6.16.5 Mindray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Blood Screening Industry Chain Analysis
7.2 Nucleic Acid Blood Screening Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Blood Screening Production Mode & Process Analysis
7.4 Nucleic Acid Blood Screening Sales and Marketing
7.4.1 Nucleic Acid Blood Screening Sales Channels
7.4.2 Nucleic Acid Blood Screening Distributors
7.5 Nucleic Acid Blood Screening Customer Analysis
8 Nucleic Acid Blood Screening Market Dynamics
8.1 Nucleic Acid Blood Screening Industry Trends
8.2 Nucleic Acid Blood Screening Market Drivers
8.3 Nucleic Acid Blood Screening Market Challenges
8.4 Nucleic Acid Blood Screening Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nucleic Acid Blood Screening Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nucleic Acid Blood Screening Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nucleic Acid Blood Screening Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nucleic Acid Blood Screening Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nucleic Acid Blood Screening Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nucleic Acid Blood Screening, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nucleic Acid Blood Screening, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nucleic Acid Blood Screening, Product Type & Application
 Table 12. Global Key Manufacturers of Nucleic Acid Blood Screening, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nucleic Acid Blood Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Blood Screening as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nucleic Acid Blood Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nucleic Acid Blood Screening Sales Market Share by Region (2020-2025)
 Table 19. Global Nucleic Acid Blood Screening Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nucleic Acid Blood Screening Sales Market Share by Region (2026-2031)
 Table 21. Global Nucleic Acid Blood Screening Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
 Table 23. Global Nucleic Acid Blood Screening Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2026-2031)
 Table 25. North America Nucleic Acid Blood Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nucleic Acid Blood Screening Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nucleic Acid Blood Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nucleic Acid Blood Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nucleic Acid Blood Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nucleic Acid Blood Screening Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nucleic Acid Blood Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nucleic Acid Blood Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nucleic Acid Blood Screening Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nucleic Acid Blood Screening Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nucleic Acid Blood Screening Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nucleic Acid Blood Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nucleic Acid Blood Screening Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nucleic Acid Blood Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nucleic Acid Blood Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nucleic Acid Blood Screening Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nucleic Acid Blood Screening Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nucleic Acid Blood Screening Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nucleic Acid Blood Screening Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nucleic Acid Blood Screening Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2020-2025)
 Table 51. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2026-2031)
 Table 52. Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
 Table 53. Global Nucleic Acid Blood Screening Sales Market Share by Type (2026-2031)
 Table 54. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2020-2025)
 Table 57. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2026-2031)
 Table 58. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nucleic Acid Blood Screening Sales (K Units) by Application (2020-2025)
 Table 61. Global Nucleic Acid Blood Screening Sales (K Units) by Application (2026-2031)
 Table 62. Global Nucleic Acid Blood Screening Sales Market Share by Application (2020-2025)
 Table 63. Global Nucleic Acid Blood Screening Sales Market Share by Application (2026-2031)
 Table 64. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2020-2025)
 Table 67. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2026-2031)
 Table 68. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Nucleic Acid Blood Screening Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Grifols Diagnostic Solutions Company Information
 Table 76. Grifols Diagnostic Solutions Description and Business Overview
 Table 77. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product
 Table 79. Grifols Diagnostic Solutions Recent Developments/Updates
 Table 80. KHB Company Information
 Table 81. KHB Description and Business Overview
 Table 82. KHB Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. KHB Nucleic Acid Blood Screening Product
 Table 84. KHB Recent Developments/Updates
 Table 85. Bacme Bio Company Information
 Table 86. Bacme Bio Description and Business Overview
 Table 87. Bacme Bio Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bacme Bio Nucleic Acid Blood Screening Product
 Table 89. Bacme Bio Recent Developments/Updates
 Table 90. Daan Gene Company Information
 Table 91. Daan Gene Description and Business Overview
 Table 92. Daan Gene Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Daan Gene Nucleic Acid Blood Screening Product
 Table 94. Daan Gene Recent Developments/Updates
 Table 95. Wantai Biotechnology Company Information
 Table 96. Wantai Biotechnology Description and Business Overview
 Table 97. Wantai Biotechnology Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Wantai Biotechnology Nucleic Acid Blood Screening Product
 Table 99. Wantai Biotechnology Recent Developments/Updates
 Table 100. Sansure Biotech Company Information
 Table 101. Sansure Biotech Description and Business Overview
 Table 102. Sansure Biotech Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sansure Biotech Nucleic Acid Blood Screening Product
 Table 104. Sansure Biotech Recent Developments/Updates
 Table 105. Zhuhai Livzon Reagents Company Information
 Table 106. Zhuhai Livzon Reagents Description and Business Overview
 Table 107. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product
 Table 109. Zhuhai Livzon Reagents Recent Developments/Updates
 Table 110. Bio-Rad Laboratories Company Information
 Table 111. Bio-Rad Laboratories Description and Business Overview
 Table 112. Bio-Rad Laboratories Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bio-Rad Laboratories Nucleic Acid Blood Screening Product
 Table 114. Bio-Rad Laboratories Recent Developments/Updates
 Table 115. Horiba Company Information
 Table 116. Horiba Description and Business Overview
 Table 117. Horiba Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Horiba Nucleic Acid Blood Screening Product
 Table 119. Horiba Recent Developments/Updates
 Table 120. Thermo Fisher Scientific Company Information
 Table 121. Thermo Fisher Scientific Description and Business Overview
 Table 122. Thermo Fisher Scientific Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Thermo Fisher Scientific Nucleic Acid Blood Screening Product
 Table 124. Thermo Fisher Scientific Recent Developments/Updates
 Table 125. bioMerieux Company Information
 Table 126. bioMerieux Description and Business Overview
 Table 127. bioMerieux Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. bioMerieux Nucleic Acid Blood Screening Product
 Table 129. bioMerieux Recent Developments/Updates
 Table 130. Danaher Company Information
 Table 131. Danaher Description and Business Overview
 Table 132. Danaher Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Danaher Nucleic Acid Blood Screening Product
 Table 134. Danaher Recent Developments/Updates
 Table 135. Abbott Company Information
 Table 136. Abbott Description and Business Overview
 Table 137. Abbott Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Abbott Nucleic Acid Blood Screening Product
 Table 139. Abbott Recent Developments/Updates
 Table 140. BD Company Information
 Table 141. BD Description and Business Overview
 Table 142. BD Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. BD Nucleic Acid Blood Screening Product
 Table 144. BD Recent Developments/Updates
 Table 145. Mindray Company Information
 Table 146. Mindray Description and Business Overview
 Table 147. Mindray Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Mindray Nucleic Acid Blood Screening Product
 Table 149. Mindray Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Nucleic Acid Blood Screening Distributors List
 Table 153. Nucleic Acid Blood Screening Customers List
 Table 154. Nucleic Acid Blood Screening Market Trends
 Table 155. Nucleic Acid Blood Screening Market Drivers
 Table 156. Nucleic Acid Blood Screening Market Challenges
 Table 157. Nucleic Acid Blood Screening Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nucleic Acid Blood Screening
 Figure 2. Global Nucleic Acid Blood Screening Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nucleic Acid Blood Screening Market Share by Type: 2024 & 2031
 Figure 4. Blood Screening Equipment Product Picture
 Figure 5. blood Screening Reagents Product Picture
 Figure 6. Global Nucleic Acid Blood Screening Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nucleic Acid Blood Screening Market Share by Application: 2024 & 2031
 Figure 8. Blood Center
 Figure 9. Central Blood Station
 Figure 10. Central Blood Bank
 Figure 11. Global Nucleic Acid Blood Screening Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Nucleic Acid Blood Screening Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Nucleic Acid Blood Screening Sales (2020-2031) & (K Units)
 Figure 14. Global Nucleic Acid Blood Screening Average Price (US$/Unit) & (2020-2031)
 Figure 15. Nucleic Acid Blood Screening Report Years Considered
 Figure 16. Nucleic Acid Blood Screening Sales Share by Manufacturers in 2024
 Figure 17. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Nucleic Acid Blood Screening Players: Market Share by Revenue in Nucleic Acid Blood Screening in 2024
 Figure 19. Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Nucleic Acid Blood Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Nucleic Acid Blood Screening Sales Market Share by Country (2020-2031)
 Figure 22. North America Nucleic Acid Blood Screening Revenue Market Share by Country (2020-2031)
 Figure 23. United States Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Nucleic Acid Blood Screening Sales Market Share by Country (2020-2031)
 Figure 26. Europe Nucleic Acid Blood Screening Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Nucleic Acid Blood Screening Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2031)
 Figure 34. China Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Nucleic Acid Blood Screening Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Nucleic Acid Blood Screening Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Nucleic Acid Blood Screening Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Nucleic Acid Blood Screening Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Nucleic Acid Blood Screening Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Nucleic Acid Blood Screening by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Nucleic Acid Blood Screening by Type (2020-2031)
 Figure 53. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Nucleic Acid Blood Screening by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Nucleic Acid Blood Screening by Application (2020-2031)
 Figure 56. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2020-2031)
 Figure 57. Nucleic Acid Blood Screening Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture